CTIX Stock | News | Quote | Stock Forum | Sunday, October 6,

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Cellceutix Corp. CTIX Company Overview 

Stock Message Board http://investorshangout.com/search?q=CTIX&...mp;yt1=Go!

Last Updated: Sunday, October 6, 2013 6:32:36 PM

Cellceutix Corp. CTIX Current Price and Quotes
Last Price 1.80
Previous Close 1.77 Open 1.72
Daily Range 1.82 - 1.71 52wk Range 2.47 - 0.77
Volume 450,269 Dividend N/A
Average Vol (3m) 310,729 Yield N/A
Cellceutix Corp. CTIX
Company Information

100 Cumming Center
Suite 151-B
Beverly, MA 01915

Website: http://www.cellceutix.com
Phone: 978-633-3623
Email: info@cellceutix.com

Cellceutix Corp. CTIX
An early stage developmental biopharmaceutical company...with six pharmaceutical compound candidates that are designed for treatment of diseases which may be either existing or diseases identified in the future. The Company will initially spend most of its efforts and resources on its anti-cancer compound, Kevetrin, for the treatment of head and neck cancers.

Cellceutix Corp. CTIX
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jun 30, 2013 10-K
CIK 0001355250
Fiscal Year End 6/30
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o May 12, 2008
Incorporated In: NV, USA
Year of Inc. 2005
Employees Not Available
Company Officers/Contacts

Krishna Menon President, CSO
Leo Ehrlich CFO, Interim CEO
Company Directors

Not Available
Company Notes

Formerly=EconoShare, Inc. until 2-2008
Service Providers

Auditor/Accountant
Baker Tilly Virchow Krause
225 S 6th Street
Suite 2300
Minneapolis, MN, 55402-4661
United States

Legal Counsel
Not Available
Investor Relations Firm
E Unum Pluribus LLC

Cellceutix Corp. CTIX
CTIX Security Details

Share Structure

Market Value1 $182,734,171 a/o Oct 04, 2013
Shares Outstanding 101,518,984 a/o Sep 17, 2013
Float Not Available
Authorized Shares 300,000,000 a/o May 12, 2008
Par Value  0.0001
Shareholders

Shareholders of Record 1,165 a/o Oct 12, 2012
Short Selling Data

Short Interest 150,953 (6.66%)
Sep 13, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

West Coast Stock Transfer Inc.

Cellceutix Corp. CTIX Recent News

Oct 2, 2013 Cellceutix Completes Final Study to File IND Application for New Psoriasis Drug Prurisol(TM)
Sept 24, 2013 Cellceutix Plans Phase 2b Trial of New Antibiotic, Reports Fifth Cohort Complete in Novel Cancer Drug Clinical Trial
Sept 16, 2013 Cellceutix Completes Acquisition of PolyMedix Assets, Immediately Plans Brilacidin(TM) Phase 2b Clinical Trial for Acute Bacterial Skin and Skin Structure Infections (ABSSSI) and Phase 2 Clinical Trial for Oral Mucositis
Sept 9, 2013 Cellceutix Acquires PolyMedix Assets From Bankruptcy Court, Gains Ownership of Two Clinical Stage Drugs, Multiple Compounds, and Equipment Assets
Sept 6, 2013 OTC Signal Daily Stock Watch - Cellceutix Corp. (OTCQB: CTIX)
Aug 26, 2013 Cellceutix Presenting at 15th Annual Rodman & Renshaw Investment Conference
Aug 12, 2013 Cellceutix Clinical Study on Its Anti-Psoriasis Drug Prurisol(TM) to Commence
Jul 26, 2013 OTC Daily Alert Stock Watch
Jul 22, 2013 XUII, FNMA, CTIX and SGLB added to OTC Active Stock Watch List at EPR


Cellceutix Corp. CTIX Financials
Period Ending Jun 30, 2013 Jun 30, 2012 Jun 30, 2011 Jun 30, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses

Research and Development 1,510 633 1,339 2,001
Sales, General and Admin. 1,473 3,564 4,383 1,363
Non-Recurring Items - - - -
Other - - - -
Operating Income (2,983) (4,197) (5,722) (3,364)
Income From Continuing Operations

Add'l Income/Expense Items - (440) - -
Earnings Before Interest and Tax (2,983) (4,637) (5,722) (3,433)
Interest Expense 241 257 216 -
Earnings Before Tax (3,224) (4,894) (5,938) (3,433)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (3,224) (4,894) (5,938) (3,433)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (3,224) (4,894) (5,938) (3,433)
Preferred Stock and Other Adjustments (212) (66) - -
Net Income Applicable to Common Shareholders (3,436) (4,960) (5,938) (3,433)

CTIX Cellceutix Corp. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=CTIX&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/CTIX/quote
Stock Chart http://www.otcmarkets.com/stock/CTIX/chart
Company Info http://www.otcmarkets.com/stock/CTIX/company-info
Recent News http://www.otcmarkets.com/stock/CTIX/news
Financials http://www.otcmarkets.com/stock/CTIX/financials
Filings and Disclosure http://www.otcmarkets.com/stock/CTIX/filings
Short Sales http://www.otcmarkets.com/stock/CTIX/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/CTIX/insider-transactions
Research Reports http://www.otcmarkets.com/stock/CTIX/research
Summary http://finance.yahoo.com/q?s=CTIX
Historical Prices http://finance.yahoo.com/q/hp?s=CTIX+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=CTIX
Basic Chart http://finance.yahoo.com/q/bc?s=CTIX+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=CTIX+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=CTIX+Headlines
Press Releases http://finance.yahoo.com/q/p?s=CTIX+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=CTIX+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=CTIX+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=CTIX+Industry
Major Holders http://finance.yahoo.com/q/mh?s=CTIX+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=CTIX+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=CTIX+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=CTIX
Balance Sheet http://finance.yahoo.com/q/bs?s=CTIX
Cash Flow http://finance.yahoo.com/q/cf?s=CTIX+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/CTIX
Market Watch http://www.marketwatch.com/investing/stock/CTIX
Bloomberg http://www.bloomberg.com/quote/CTIX:US
Morningstar http://quotes.morningstar.com/stock/s?t=CTIX
Bussinessweek http://investing.businessweek.com/research/st...icker=CTIX
Barchart http://www.barchart.com/quotes/stocks/CTIX
OTC Short Report http://otcshortreport.com/index.php?index=CTIX
Investopedia http://www.investopedia.com/markets/stocks/CTIX/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 71

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 675

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 273

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 167

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 115

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 351

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 373

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 135

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 189

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 103

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading

Top 5 Most Recently Viewed Articles

Leadership Transition at Ignitis Renewables Sparks Future Growth

Updated Category News Views 134

Leadership Transition at Ignitis Renewables AB “Ignitis grup?” has announced a significant change in leadership with the resignation of Thierry Aelens, the Chief Executive Officer (CEO) of its subsidiary, UAB “Ignitis Renewables.” Aelens will step down effective at the end of March 2025 for personal reasons and to pursue new career opportunities nearer to his...

Continue Reading
Katalyze AI Elevates Innovation with New Chief AI Officer

Updated Category News Views 206

Advancing Pharmaceutical Manufacturing with AI Leadership Katalyze AI has recently announced a pivotal move to strengthen its capabilities in the fast-evolving field of pharmaceutical manufacturing. The company has appointed Hannes Bretschneider as Chief AI Officer, signaling its commitment to advancing Agentic AI architecture. This strategic initiative aims to enhance...

Continue Reading
Iran's Strait Closure: Defense Stocks on Edge Amid Shipping Risks

Updated Category News Views 325

Iran announced the temporary closure of the Strait of Hormuz for live-fire drills, raising eyebrows across trading desks. This isn't just a geopolitical stunt; it’s a shot across the bow at U. S. military presence in the region, occurring right as indirect nuclear talks unfold with Washington. A maneuver like this sends ripples through markets that thrive on stability,...

Continue Reading
Aphaia Pharma's Engagement in Revolutionary Obesity Forum

Updated Category News Views 117

Aphaia Pharma's Engagement in Revolutionary Obesity Forum Aphaia Pharma, a leading clinical-stage biopharmaceutical company, is making waves in the field of treatments for obesity and related metabolic disorders. The company has announced that its Chief Scientific Officer, Dr. Steffen-Sebastian Bolz, will share insights during a panel discussion at the much-anticipated...

Continue Reading
U.S. Strives to Diminish China's Dominance in Rare Earths

Updated Category News Views 216

Understanding the Importance of Rare Earth Elements In recent discussions, the significance of rare earth elements (REEs) has come to the forefront of international policy. These elements play a crucial role in various sectors, from technology to defense. Currently, China holds a dominant position in the production and refinement of these vital minerals, controlling...

Continue Reading